Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients

University of Zurich25 enrolled

Overview

Photosensitivity of the skin to UVA and UVB will be determined

Photosensitivity of the skin to UVA and UVB in renal transplant recipients with and without azathioprine will be determined. Azathioprine will be discontinued and photosensitivity determined after a wash-out period of three months * Trial with medicinal product

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Skin Cancer

Interventions

Discontinuation of AzathioprinDRUG

Discontinuation of Azathioprin

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion criteria: * Renal transplant recipients under azathioprin Exclusion criteria: * Treatment with Prograf (Tacrolimus)

Locations (1)

Clinic for Dermatology, University Hospital of Zurich

Zurich, Switzerland

Outcomes

Primary Outcomes

Photosensitivity of the skin to UVA and UVB

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.